---
title: European LeukemiaNet laboratory recommendations for the diagnosis and management
  of chronic myeloid leukemia
date: '2023-10-04'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37794101/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231005180843&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: From the laboratory perspective, effective management of patients with
  chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic
  markers, sequential assessment of levels of residual disease and investigation of
  possible reasons for resistance, relapse or progression. Our scientific and clinical
  knowledge underpinning these requirements continues to evolve, as do laboratory
  methods and technologies. The European LeukemiaNet convened an expert panel to ...
disable_comments: true
---
From the laboratory perspective, effective management of patients with chronic myeloid leukemia (CML) requires accurate diagnosis, assessment of prognostic markers, sequential assessment of levels of residual disease and investigation of possible reasons for resistance, relapse or progression. Our scientific and clinical knowledge underpinning these requirements continues to evolve, as do laboratory methods and technologies. The European LeukemiaNet convened an expert panel to ...